Stock Analysis
Insulet Corp. (PODD) Stock Analysis
Insulet Corp. (PODD) stock analysis covering valuation, fundamentals, technical indicators, risk, AIQ Momentum, analyst catalysts, dividends, and the current AIQ Score.
Insulet Corp. (PODD) currently has an AIQ Score of 51/100, indicating a neutral setup. Quality is the strongest factor at 77/100. Momentum is the weakest current factor at 22/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.
PODD at a Glance
Crawlable current metrics from the latest market-close stock snapshot.
| Metric | Current |
|---|---|
| Price | $131.96 |
| AIQ Score | 51/100 |
| Overall View | Neutral |
| Technical Analysis Consensus | Strong Sell |
| Market Cap | $10.28B |
| P/E Ratio | 25.28 |
| Forward P/E | — |
| EPS | $1.37 |
| Revenue TTM | $801.7M |
| Dividend Yield | 0.00% |
| Beta | 1.1 |
| Volume | 1.75M |
| 52-week range | $126.40-$354.88 |
| RSI 14 | 24.92 |
| 50-Day SMA | $152.70 |
| 200-Day SMA | $206.32 |
| Analyst Price Target | $213.22 |
| Next Earnings | Nov 5, 2026 |
PODD
OverviewPODD Stock Analysis Summary
Insulet Corp. (PODD) currently has an AIQ Score of 51/100, indicating a neutral setup. Quality is the strongest factor at 77/100. Momentum is the weakest current factor at 22/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.
In a neutral regime, PODD has AIQ Score of 51/100 with Quality base of 77/100 and fading Momentum at 22/100. Wait for component alignment before adding exposure.
Quality (77/100) leads while Momentum (22/100) lags. This cross-factor spread creates entry timing uncertainty.
Healthcare · -2.02% stock move · PODD classified in Medical - Devices.
Current Evidence
AlgovestIQ Evidence Summary
Current consensus, supporting evidence, recent changes, and what would strengthen or weaken the view.
Is PODD Bullish or Bearish Right Now?
PODD currently has a neutral overall setup. Quality is the strongest factor at 77/100, while Momentum is weakest at 22/100. The current evidence suggests a mixed rather than strongly bullish or bearish setup.
- - Quality is supportive at 77/100.
- - Analyst target implies +61.58% upside from the latest quote.
- - Momentum is weak at 22/100.
- - Price is -36.04% below its 200-day SMA.
- - Technical consensus has more sell votes than buy votes (36 vs 8).
Current Consensus
PODD's Technical Analysis Consensus is currently Strong Sell, with 8 buy, 1 neutral, and 36 sell votes. PODD's 14-day RSI is 24.92, which places the stock in an oversold momentum range. PODD's beta is 1.1, indicating market sensitivity broadly in line with the market.
What Changed in PODD?
Recent score-change history is not available in the current snapshot. These are the latest market-close scores instead.
What Would Change the PODD Outlook?
The current neutral outlook could improve if AIQ moves above 70, momentum recovers, earnings revisions strengthen, and price confirms a stronger trend above the 50-day and 200-day moving averages. It would weaken if AIQ falls below 40, price loses long-term moving-average support, analyst expectations deteriorate, or risk evidence worsens.
AIQ > 70, RSI above 55, price above SMA-50/SMA-200, and positive catalyst or estimate-revision evidence.
AIQ below 40, RSI below 45, loss of SMA-200, negative revisions, or rising volatility and drawdown risk.
PODD Decision Framework
Public evidence layers, setup checks, and risk context for Insulet Corp..
Insulet Corp. (PODD) Stock Analysis
Insulet Corp. has an AIQ Score of 51/100 in a Neutral regime. Quality is strongest at 77/100. Beta is 1.1, close to market sensitivity. Review the supporting stock factors together before drawing a conclusion from any single score.
| Evidence Layer | Public Evidence |
|---|---|
| Regime Context | PODD is in a Neutral AIQ regime with score 51/100. |
| Signal Conflict | The primary conflict is that quality leads at 77/100 while momentum lags at 22/100. |
| Factor Evidence | Momentum 22/100 · Value 46/100 · Quality 77/100 · Risk 59/100 |
| Persistence | Current snapshot evidence is shown; historical persistence remains in AIQ Pro. |
Current Setup Checklist
Quality is the strongest factor at 77/100.
Momentum is 22/100 and RSI (14) is 24.9.
PODD is in a Neutral regime at 51/100.
Risk factor is 59/100 with beta 1.1 and annual volatility 44.63%.
Current conflict: quality leads at 77/100 while momentum lags at 22/100.
PODD Research Cluster
Ticker-specific paths for valuation, technical analysis, catalysts, dividends, financials, risk, and news.
PODD Fundamentals
PODD valuation, profitability, growth, margins, balance-sheet strength, and free cash flow.
PODD Technical Analysis
PODD technical setup based on RSI, MACD, moving averages, AIQ Momentum, volume, trend, volatility, and pivots.
PODD Stock Catalysts
Track PODD earnings, analyst ratings, price targets, estimate revisions, stock news, and upcoming events.
PODD Dividend Analysis
PODD dividend yield, annual dividend, payout ratio, payment history, and income reliability context.
PODD Financial Data
PODD revenue, earnings, income statement, balance sheet, cash flow, valuation ratios, and stock metrics.
PODD Risk Analysis
PODD volatility, beta, drawdown, Sharpe ratio, VaR, and downside resilience.
PODD Stock News
PODD stock news, market tone, recent headlines, and catalyst context.
PODD vs Medical Devices Peers
Current peer cohort: PODD · RMD · SOLV · STE · SYK. Compare AIQ, factor scores, Sharpe ratio and 1-year volatility in one indexable view.
| Peer | AIQ | Value | Momentum | Risk | Sharpe | 1Y Volatility | Compare |
|---|---|---|---|---|---|---|---|
| PODD Current stock | 51/100 | 46/100 | 22/100 | 59/100 | -1.97 | 44.63% | Current |
| RMD ResMed | 54/100 | 42/100 | 29/100 | 70/100 | -0.75 | 28.46% | PODD vs RMD |
| SOLV Solventum | 61/100 | 67/100 | 50/100 | 56/100 | 0.71 | 29.78% | PODD vs SOLV |
| STE Steris | 46/100 | 48/100 | 15/100 | 72/100 | -0.6 | 25.56% | PODD vs STE |
| SYK Stryker | 43/100 | 42/100 | 8/100 | 55/100 | -1.1 | 29.49% | PODD vs SYK |
Peer cohort is resolved dynamically from the AlgovestIQ universe taxonomy and Compare relationship graph. Data as of Sep 11, 2026.
About the AIQ Score
Methodology for the current stock evidence.
The AlgovestIQ AIQ Score combines multiple dimensions of stock evidence, including momentum, valuation exposure, quality, risk resilience, sentiment context, and timing signals. It is a descriptive research score, not a guarantee of future performance or a personalized recommendation.
View AIQ methodologyFactor Diagnostics
A compact bridge from the AIQ score to the evidence tabs.
Open the return calculator with stock context while purchase price, shares, dates and fees remain user inputs.
AIQ Component Profile
Compare the five component scores on one consistent 0–100 scale.
Review earnings timing, revisions, news pressure, and prior event reactions in one place.
Open catalysts8 recent quarterly periods are available for review.
Checked Sep 12, 2026
Explore factor drivers, conflicts, persistence, and scenario sensitivity in the advanced workspace.
Fundamentals Verdict
Current snapshot fields are separate from reported-quarter statement tables.
Latest period Jun 30, 2026.
Market Confirmation
Technicals are summarized first, with the indicator library behind it.
Risk Alignment
Higher resilience is stronger; exposure metrics stay separate.
Continue Researching PODD
Open the detailed evidence pages and workflows behind the stock overview read.
Premium Feature
Full AIQ Analysis
AIQ Intelligence
AIQ Pro for PODD
Scenario Analysis
AIQ Scenario Builder
Portfolio Implication
Related Links
PODD Stock FAQ
What is PODD stock price today?
Insulet Corp.'s current stock price is $131.96. Use the live quote with AIQ Score, news, and risk context rather than treating price alone as a decision signal.
Is PODD bullish or bearish right now?
PODD's bullish or bearish read depends on the current AIQ Score, factor alignment, technical analysis consensus, valuation, risk, and catalyst evidence. A mixed setup should be treated differently from a broad confirmation across those signals.
What is PODD's market cap?
PODD's market cap is $10.28B based on the latest completed market-close snapshot from Sep 11, 2026. Use it with P/E ratio, revenue, and growth metrics to frame company size, valuation, and peer comparisons.
What is PODD's current P/E ratio?
PODD's current P/E ratio is 25.28 based on the latest completed market-close snapshot from Sep 11, 2026. Read it with revenue growth, margins, EPS, cash flow, and peer valuation rather than using P/E alone.
What is PODD's RSI?
PODD's 14-day RSI is 24.92 based on the latest completed market-close snapshot from Sep 11, 2026. RSI should be interpreted with MACD, moving averages, volume, volatility, and price trend.
Is PODD above its 50-day and 200-day moving averages?
PODD is -13.58% from its 50-day SMA and -36.04% from its 200-day SMA based on the latest completed market-close snapshot from Sep 11, 2026. Moving-average position should be read with momentum and broader AIQ evidence.
When is PODD's next earnings date?
PODD's next earnings date is currently listed as Nov 5, 2026. Earnings can reset revenue, EPS, price target, analyst rating, and catalyst expectations.
Does PODD pay a dividend?
PODD's dividend yield is 0.00% based on the latest completed market-close snapshot from Sep 11, 2026. Dividend yield should be read with payout ratio, free cash flow, growth, and balance-sheet strength.